Ligence Heart vs Zio AT ECG Monitoring System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Ligence
VS
by iRhythm Technologies, Inc.

AI Verdict

These tools are adjacent in the cardiology AI space but serve distinct diagnostic purposes. Ligence Heart automates the analysis of 2D transthoracic echocardiography for structural and functional heart assessment. In contrast, the Zio AT ECG Monitoring System provides continuous, AI-powered ECG monitoring specifically for long-term arrhythmia detection.

Choose Ligence Heart if…

Choose Ligence Heart if your cardiology department aims to significantly enhance the efficiency and accuracy of 2D transthoracic echocardiography analysis and reporting. This platform is ideal for automating complex measurements, classifying views, and generating comprehensive reports, allowing cardiologists and sonographers to streamline their workflow and improve diagnostic throughput for conditions like heart failure and valvular diseases.

View Ligence Heart →

Choose Zio AT ECG Monitoring System if…

Choose Zio AT ECG Monitoring System if you require a reliable, long-term solution for continuous ambulatory ECG monitoring to detect and diagnose cardiac arrhythmias in patients. This wearable system is best suited for identifying both symptomatic and asymptomatic cardiac events over an extended period (up to 14 days), providing comprehensive data for clinicians to manage patients with suspected or known arrhythmias.

View Zio AT ECG Monitoring System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Ligence Heart Zio AT ECG Monitoring System
Pricing Contact-for-pricing Contact for pricing
Deployment Cloud-based; on-premise; hybrid Cloud-based (data analytics and clinician portal)
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Both tools demonstrate strong usability tailored to their respective users. Ligence Heart excels in streamlining complex diagnostic workflows for cardiologists and sonographers through an intuitive, web-based interface and automation. Zio AT, on the other hand, provides excellent patient usability with its comfortable wearable, high compliance rates, and comprehensive clinician portal with seamless EHR integration.

Clinical Value

Tie

Both tools offer significant and well-validated clinical value in different areas of cardiology. Ligence Heart provides enhanced accuracy and efficiency in echocardiography analysis, aiding in the diagnosis of structural heart diseases and reducing inter-operator variability. Zio AT excels in long-term, continuous arrhythmia detection, leading to earlier diagnosis and improved patient outcomes compared to traditional methods.

Pricing & Value

Tie

Both tools employ opaque, enterprise-level pricing models, requiring direct contact for specific quotes, which makes a direct cost comparison impossible. However, both articulate strong value propositions: Ligence Heart through workflow efficiency and diagnostic accuracy, and Zio AT through superior diagnostic yield and improved patient outcomes, which translate to health economic benefits.

Enterprise Readiness

Ligence Heart

While both are highly enterprise-ready with FDA clearance, HIPAA compliance, BAA availability, and strong integration capabilities, Ligence Heart offers more flexible deployment options (cloud, on-premise, hybrid) [JSON, cite: 3, 24]. This flexibility can be a critical advantage for large healthcare systems with diverse IT infrastructures or strict data residency requirements, giving it a slight edge.

Innovation

Tie

Both tools represent significant innovation in cardiology AI. Ligence Heart's automation of complex echocardiography interpretation, potentially surpassing human performance and standardizing diagnostics, is highly innovative. Zio AT's long-term wearable monitoring combined with advanced AI for continuous arrhythmia detection also pushes the boundaries of remote cardiac diagnostics and patient care.

Support & Docs

Tie

Both companies clearly provide customer support contact information and make user manuals or clinical reference materials available. Ligence Heart lists a dedicated customer service email and user manuals. Zio AT provides a customer service phone number for both patients and providers, along with clinical reference manuals and instructions for use. Neither tool's documentation provides enough detail to distinguish a superior offering in terms of the breadth or depth of support and documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Ligence Heart Zio AT ECG Monitoring System
Tool Name Ligence Heart Zio AT ECG Monitoring System
Company Ligence iRhythm Technologies, Inc.
Description AI-powered web-based platform that automates the analysis and reporting of 2D transthoracic echocardiography, enhancing diagnostic efficiency and accuracy for cardiologists and sonographers. FDA-cleared, wearable mobile cardiac telemetry (MCT) service offering continuous, AI-powered ECG monitoring for long-term arrhythmia detection and comprehensive reporting.
Key Features Automated recognition of echocardiography imaging data; Automated view classification and heart phase prediction; Automated calculation of measurements and report generation; Transfer of echocardiography images (PHI removed) from hospital PACS; Area, Distance, Doppler, and Volume quantification; Disease recognition (Heart failure, cardiomyopathy, pulmonary hypertension, valvular heart diseases); Automated strain, Spectral and Tissue Doppler measurements; Integration with existing systems (PACS, EHR, RIS) Wearable Zio AT patch for continuous ECG recording; Wireless gateway for real-time data transmission; FDA-cleared deep-learned AI algorithm (ZEUS System) for arrhythmia detection; Continuous, uninterrupted ECG recording for up to 14 days; Detection of symptomatic and asymptomatic cardiac events; Comprehensive end-of-wear reports for clinicians; ZioSuiteu00ae clinician portal and mobile app for patient management and report interpretation; MyZiou00ae patient mobile app for symptom logging and education
Categories Cardiology AI Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties Cardiology Cardiology

Videos

Demos, reviews, and walkthroughs featuring Ligence Heart and Zio AT ECG Monitoring System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Ligence Heart is an AI-powered platform that automates the analysis and reporting of 2D transthoracic echocardiography, enhancing diagnostic efficiency and accuracy for structural and functional heart conditions. In contrast, the Zio AT ECG Monitoring System is a wearable mobile cardiac telemetry service offering continuous, AI-powered ECG monitoring specifically for long-term arrhythmia detection.
Ligence Heart processes existing echocardiography imaging data, transferring de-identified images (PHI removed) from hospital PACS for automated analysis and report generation. The Zio AT system utilizes a wearable patch for continuous ECG recording, transmitting real-time data wirelessly via a gateway to a cloud-based platform for AI-powered arrhythmia detection.
Ligence Heart is designed for disease recognition related to heart failure, cardiomyopathy, pulmonary hypertension, and valvular heart diseases through automated echocardiography analysis. The Zio AT ECG Monitoring System focuses on the detection of symptomatic and asymptomatic cardiac events, primarily various arrhythmias, through continuous ECG monitoring for up to 14 days.
Ligence Heart explicitly offers integration with existing systems such as PACS, EHR, and RIS, and facilitates the transfer of echocardiography images from PACS. The Zio AT system provides a ZioSuiteu00ae clinician portal and mobile app for patient management and report interpretation, and also offers EHR integration, including seamless transmission of orders and results with Epic via the Aura network.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.